Microdosing Pharmaceutical Topical 
MMJ Recs
JANUARY 17, 2024
Cannabis can also enhance the efficacy of conventional treatments, potentially allowing patients to reduce reliance on traditional pharmaceuticals with a myriad of side effects. For quick relief, smoking or vaporizing flower may be effective, while topicals like balms and creams can target localized pain.
The Cannigma
JUNE 24, 2021
While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. These natural alternatives may also be effective as part of a daily “microdosing” regiment. Part of a natural, alternative lifestyle.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaTech
DECEMBER 15, 2019
When patients understand their disease state, how the endocannabinoid system interacts with all their other systems, comprehends the concept of microdosing, as well as the different components of different strains, and the many different methods of consumption available, we see amazing things. This is a pretty big number to digest.
Cannabis Law Report
SEPTEMBER 10, 2019
” Here’s some of the topics covered in their latest newsletter. Schedule I drugs have no accepted medical use, while Schedule IV drugs include pharmaceuticals such as benzodiazepines. Garcia-Romeu Comments on Recent Study of Psychedelic Microdosing in Rats. Psychedelic Research News.
Canna Law Blog
NOVEMBER 15, 2021
Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). This is a topic we have covered regularly on the Canna Law Blog, most recently by Mason Marks , here. Pharmaceutical start-ups are betting on the treatment potential of psychedelics.
Canna Law Blog
NOVEMBER 27, 2021
Several months ago, Canada-based Algernon Pharmaceuticals submitted a request to U.S. In September, the Nikean Foundation announced a $5 million gift to create a psychedelic therapy research center at the University of Toronto. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction.
CannaMD
OCTOBER 7, 2019
As the study authors explain: Our theory suggests that the psychoactive effects of CB1 receptor stimulation with THC may be a necessary accompaniment to cannabis-induced weight loss, because down-regulation of CB1 receptors is required for reduced BMI, and it is not yet clear whether microdosing will cause down-regulation.
Expert insights. Personalized for you.
98 
Let's personalize your content